Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...
Next-generation Sequencing-based CE-IVD Solution Provides Accurate, Reliable, Fast and Scalable End-to-end Genome-wide Noninvasive Prenatal Testing Illumina's VeriSeq NIPT Solution v2 (Photo: Business ...
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention.
On Monday, Illumina, Inc. (NASDAQ:ILMN) agreed to acquire Standard BioTools’ (NASDAQ:LAB) subsidiary, SomaLogic. Following the announcement of the acquisition, Standard BioTools’ stock experienced a ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
MELBOURNE, Australia--(BUSINESS WIRE)--Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback